Skip to main content
Watch Insiders
ZVRAHealthcare

Zevra Therapeutics Inc (ZVRA) Insider Trading

In the last 90 days, 3 Zevra Therapeutics Inc (ZVRA) insiders reported no open-market purchases and 3 sales totaling $838,100. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 12, 2026Neil F. McFarlanePresident and CEOSale20,000$11.25$224,948
Aug 14, 2026Rahsaan ThompsonChief Legal & ComplianceSale42,666$11.13$474,774
Aug 10, 2026Corey Michael WattonCorporate insiderSale12,300$11.25$138,377
Jun 22, 2026Rahsaan ThompsonChief Legal & ComplianceSale34,557$12.68$438,304
May 11, 2026Rahsaan ThompsonChief Legal & ComplianceSale1,794$11.30$20,272

Common questions

ZVRA insider trading FAQ

Are ZVRA insiders buying or selling?
Over the last 90 days, ZVRA insiders were net sellers, reporting $0.00 of open-market purchases and $838,100 of sales.
When was the last ZVRA insider purchase?
No open-market insider purchase of Zevra Therapeutics Inc stock was reported in the last 90 days.
Where does ZVRA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Zevra Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.